Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 5:15:1553681.
doi: 10.3389/fcimb.2025.1553681. eCollection 2025.

Detection assay of polymyxin resistance coding mcr-1 gene based on CRISPR/Cas13a system

Yingjie Song #  1 , Qiang Hu #  1 , Yao Han  1 , Hongbo Liu  2 , Zhenyang Huang  1 , Mengwei Niu  1 , Xue Dong  1 , Kuocheng Yan  1 , Li Jin  1 , Hao Li  1 , Yansong Sun  1
Affiliations

Detection assay of polymyxin resistance coding mcr-1 gene based on CRISPR/Cas13a system

Yingjie Song et al. Front Cell Infect Microbiol. .

Abstract

Introduction: Polymyxins are reserved as an ultimate defense against multidrug-resistant bacteria. The emergence of the polymyxin resistance gene mcr-1 poses a potential risk for the treatment of severe infections caused by Gram-negative bacteria. Timely detection and monitoring the mcr-1 gene are essential for guiding anti-infective therapy and controlling the spread of polymyxin resistance. Quantitative real-time PCR (qPCR) is one of the common methods for detecting resistance genes. However, qPCR has equipment dependency, and is not feasible in primary healthcare settings. Currently, there remains a lack of a highly sensitive and portable method for detecting the mcr-1 gene.

Methods: We established and optimized detection assays of the mcr-1 gene based on CRISPR/Cas13a system and lateral flow strips. The detection method was preliminarily evaluated using clinical isolates from Escherichia coli, compared with qPCR.

Results: The method for detecting the mcr-1 gene based on the CRISPR/Cas13a system and lateral flow strips was established, with a detection limit of 100 copies/mL. This method demonstrated high analytical specificity, with no cross-reactivity detected in non-mcr-1 and non-resistant strains. Among 36 clinical isolates, the method identified 31 strains as positive for the mcr-1 gene, and had a 100% concordance rate with the results of qPCR.

Conclusions: We established a detection method for the polymyxin resistance mcr-1 gene based on the CRISPR/Cas13a system. This method enables visual readouts without instruments, making it potentially applicable to primary healthcare settings and field surveillance.

Keywords: CRISPR/Cas13a; antibiotic resistance; lateral flow strip; mcr-1; polymyxin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The schematic of CRISPR-ERASE assay for detecting the mcr-1 gene. Plasmid DNA was extracted from Escherichia coli, amplified the mcr-1 gene fragment by recombinase-assisted amplification (RAA) and transcribed into an RNA sequence. When CRISPR/Cas13a system recognizes the RNA target and degrades reporter RNA. The cleaved reporter RNA can be captured on a lateral flow strip and the results can be read with the naked eye using ERASE strips.
Figure 2
Figure 2
Design and screening of RAA primers and crRNAs for the detection of the mcr-1 gene. (A) The schematic diagram of the design of RAA primers and crRNA. (B) The dynamic fluorescence curves within 40 min of 3 different crRNAs for CRISPR-ERASE assay (n = 3). (C) The fluorescence values of different crRNAs designed for the mcr-1 gene were compared at the 40 min after detection reaction. ****p < 0.0001. The data were expressed as mean ± SEM (n = 3). (D) The fluorescence values produced at 40 min of CRSIPR fluorescence detection reaction with crRNA-1 and different RAA amplification primer combinations of mcr-1 gene. The data were expressed as mean ± SEM (n = 3).
Figure 3
Figure 3
Analytical sensitivity and specificity evaluation of the CRISPR-ERASE assay for the detection of the mcr-1 gene. (A) Comparison of fluorescence values produced by CRISPR fluorescence detection of mcr-1 plasmid. TH means the threshold using the mean fluorescence value of the negative control group plus three times the standard deviation. ***p<0.001; ****p<0.0001. The data were expressed as mean ± SD (n = 3). (B) The results of qPCR at different mcr-1 plasmid concentrations (103 ~10-1 copies/μL) (n = 3). (C) The results of CRISPR-ERASE at different mcr-1 plasmid concentrations (103 ~10-1 copies/μL). Test band disappeared and control band was visible meaning that the test result is positive. Repeat each result three times. NC represents Negative Control. (D) CRISPR-ERASE assay was used to detect the mcr-1 gene of different strains. PC represents Positive Control; Escherichia coli (+) represents mcr-1-positive Escherichia coli; S.aureus represents Staphylococcus aureus; H. pylori represents Helicobacter pylori; K. pneumoniae represents Klebsiella pneumoniae (n = 3).
Figure 4
Figure 4
Preliminary validation of CRISPR-ERASE detection system to detect mcr-1 gene in isolated Escherichia coli samples. (A) The results of antimicrobial susceptibility testing for NO.31-33 isolated samples. (B) The MIC results of antimicrobial susceptibility testing for 36 isolated samples. (C) The results of CRISPR-ERASE detection assay for 36 isolated samples. PC represents Positive Control.NC represents Negative Control. (D) The results of qPCR for 36 isolated samples.
See this image and copyright information in PMC

References

    1. Al-Tawfiq J. A., Laxminarayan R., Mendelson M. (2017). How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? Int. J. Infect. Dis. 54, 77–84. doi: 10.1016/j.ijid.2016.11.415 - DOI - PubMed
    1. Andersson D. I., Hughes D., Kubicek-Sutherland J. Z. (2016). Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist. Update 26, 43–57. doi: 10.1016/j.drup.2016.04.002 - DOI - PubMed
    1. Armbrecht L., Rutschmann O., Szczerba B. M., Nikoloff J., Aceto N., Dittrich P. S. (2020). Quantification of protein secretion from circulating tumor cells in microfluidic chambers. Adv. Sci. (Weinh) 7, 1903237. doi: 10.1002/advs.201903237 - DOI - PMC - PubMed
    1. Bartels M. D., Worning P., Andersen L. P., Bes M., Enger H., Ås C. G., et al. (2021). Repeated introduction and spread of the MRSA clone t304/ST6 in northern Europe. Clin. Microbiol Infect. 27, 284.e281–284.e285. doi: 10.1016/j.cmi.2020.05.004 - DOI - PubMed
    1. Chabou S., Leangapichart T., Okdah L., Le Page S., Hadjadj L., Rolain J. M. (2016). Real-time quantitative PCR assay with Taqman(®) probe for rapid detection of MCR-1 plasmid-mediated colistin resistance. New Microbes New Infect. 13, 71–74. doi: 10.1016/j.nmni.2016.06.017 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources